Abstract
HTX-019 is a neurokinin 1 receptor antagonist approved for prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients with c......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
